Author
|
Topic: Investor eyes ISS as pharma lab
|
Robert Pearlman Editor Posts: 42988 From: Houston, TX Registered: Nov 1999
|
posted 10-08-2007 12:27 AM
From Wired.com: Texas Investor Eyes Space Station as Orbiting Pharma Lab quote: "If people knew what I already know, the International Space Station would be considered one of the most valuable resources our world possesses," Pickens said at the ISS National Laboratory Workshop last week. "There are things you can only do in microgravity that will eventually lead to products that could save millions of lives."
|
Lunar rock nut Member Posts: 911 From: Oklahoma city, Oklahoma U.S.A. Registered: Feb 2007
|
posted 10-08-2007 07:09 AM
I hope that this statement receives the attention that it deserves. Ten years ago I would have thought by today I would be reading about new medicines being developed on a regular basis onboard the ISS.I wonder if he has made a reservation with Space Adventures. Terry |
KSCartist Member Posts: 2896 From: Titusville, FL USA Registered: Feb 2005
|
posted 10-08-2007 07:34 AM
As mentioned by others, this is the perfect solution for the ISS after the US stops funding in 2015.Let private enterprise use this facility for R & D of products like this. Tim |
capoetc Member Posts: 2169 From: McKinney TX (USA) Registered: Aug 2005
|
posted 10-08-2007 09:07 AM
quote: Originally posted by KSCartist: As mentioned by others, this is the perfect solution for the ISS after the US stops funding in 2015.
I had not heard the 2015 date before, I must not have been paying attention. Is this confirmed?------------------ John Capobianco Camden DE |
Robert Pearlman Editor Posts: 42988 From: Houston, TX Registered: Nov 1999
|
posted 10-08-2007 12:06 PM
quote: Originally posted by capoetc: I had not heard the 2015 date before, I must not have been paying attention. Is this confirmed?
For budgeting purposes, NASA has set 2016 as the end of its participation in the ISS, though the agency has also reportedly a policy not to do anything that would preclude continued operations beyond that date. At NASA's present funding levels, there just isn't enough money to support ISS ops and stage a return to the Moon. To that end, the 2005 NASA Authorization Act designated the U.S segment of the ISS as a national laboratory and directed the agency to develop a plan to "increase the utilization of the ISS by other Federal entities and the private sector." Under this directive, NASA signed a memorandum of agreement with the National Institutes of Health in September. |